Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$1.16B |
| 3 |
Amazon
AMZN
|
+$797M |
| 4 |
Tesla
TSLA
|
+$537M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$441M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
Exelon
EXC
|
+$46.4M |
| 5 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
Sector Composition
| 1 | Technology | 28.24% |
| 2 | Healthcare | 14.22% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.52% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Tredegar Corp
TG
$269M
| $766K | ﹤0.01% |
63,900
+4,800
| +8% | +$57.5K |
|
2502
ANI Pharmaceuticals
ANIP
$2.14B
| $759K | ﹤0.01% |
27,000
+1,800
| +7% | +$50.6K |
|
2503
Inseego
INSG
$198M
| $755K | ﹤0.01% |
18,640
+1,600
| +9% | +$64.8K |
|
2504
SIGA Technologies
SIGA
$622M
| $745K | ﹤0.01% |
105,100
+6,000
| +6% | +$42.5K |
|
|
ZOM
2505
DELISTED
Zomedica Corp.
ZOM
| $742K | ﹤0.01% |
2,201,200
+156,100
| +8% | +$52.6K |
|
2506
Axogen
AXGN
$751M
| $741K | ﹤0.01% |
93,300
+8,200
| +10% | +$65.1K |
|
2507
Oramed Pharmaceuticals
ORMP
$94.7M
| $740K | ﹤0.01% |
85,500
+21,100
| +33% | +$183K |
|
2508
Sana Biotechnology
SANA
$746M
| $738K | ﹤0.01% |
89,300
+6,500
| +8% | +$53.7K |
|
2509
Y-mAbs Therapeutics
YMAB
$389M
| $737K | ﹤0.01% |
62,000
+4,700
| +8% | +$55.9K |
|
2510
eHealth
EHTH
$119M
| $736K | ﹤0.01% |
59,300
+4,400
| +8% | +$54.6K |
|
|
KBAL
2511
DELISTED
Kimball International
KBAL
| $730K | ﹤0.01% |
86,400
+5,500
| +7% | +$46.5K |
|
2512
MeiraGTx Holdings
MGTX
$627M
| $729K | ﹤0.01% |
52,600
+3,800
| +8% | +$52.7K |
|
2513
Veru
VERU
$54.6M
| $729K | ﹤0.01% |
15,100
+1,010
| +7% | +$48.8K |
|
2514
Forestar Group
FOR
$1.39B
| $728K | ﹤0.01% |
41,017
+2,900
| +8% | +$51.5K |
|
2515
Xometry
XMTR
$2.48B
| $728K | ﹤0.01% |
19,800
+1,400
| +8% | +$51.5K |
|
2516
Skillz
SKLZ
$112M
| $722K | ﹤0.01% |
12,040
+1,015
| +9% | +$60.9K |
|
2517
Dream Finders Homes
DFH
$2.68B
| $717K | ﹤0.01% |
42,000
+2,900
| +7% | +$49.5K |
|
2518
IDEAYA Biosciences
IDYA
$2.18B
| $714K | ﹤0.01% |
63,800
+4,600
| +8% | +$51.5K |
|
2519
Treace Medical Concepts
TMCI
$454M
| $713K | ﹤0.01% |
37,700
+2,900
| +8% | +$54.8K |
|
2520
indie Semiconductor
INDI
$796M
| $711K | ﹤0.01% |
91,000
+6,200
| +7% | +$48.4K |
|
2521
Taboola.com
TBLA
$1.01B
| $711K | ﹤0.01% |
137,700
+11,600
| +9% | +$59.9K |
|
2522
EverQuote
EVER
$856M
| $710K | ﹤0.01% |
43,900
+4,000
| +10% | +$64.7K |
|
|
VBIV
2523
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $707K | ﹤0.01% |
14,193
+1,090
| +8% | +$54.3K |
|
2524
Ribbon Communications
RBBN
$694M
| $706K | ﹤0.01% |
228,474
+16,900
| +8% | +$52.2K |
|
2525
Tango Therapeutics
TNGX
$725M
| $706K | ﹤0.01% |
93,100
+6,400
| +7% | +$48.5K |
|